MedPath

Efficacy of Testosterone gel to restore normal serum values of testosterone during the acute phase of critical illness in adult ICU patients

Phase 1
Conditions
- Hypermetabolism in ICU, loss of muscle mass and functional disability after ICU - ICU acquired hypogonadism - Treatment with testosterone gel in ICU
Therapeutic area: Diseases [C] - Hormonal diseases [C19]
Registration Number
EUCTR2017-004978-34-FR
Lead Sponsor
CHU de Clermont-ferrand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

-Males and females aged over 18 years receiving invasive mechanical ventilation
-Invasive mechanical ventilation expected to be required for more than 48 hours
-Treatment with vasoactive drugs
-Written informed consent obtained from the legal representative
-Social security cover

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 30
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 30

Exclusion Criteria

•History of prostate or breast cancer, prostatic specific antigen (PSA) = 4 ng/ml
•ICU length of stay > 72 h before enrollment
•Moribund defined as having a score SAPS II > 75 12 hours after admission
•Pre-existing illness with a life expectancy of <6 months
•Cardiac arrest
•Preexistent cognitive impairment or language barrier
•Acute intracranial or spinal cord injury
•Acute hemorrhagic or ischemic stroke
•Neuromuscular disease (Guillain-Barré, myasthenia)
•Inability to walk without assistance prior to acute ICU illness (use of a cane or walkers not excluded)
•Documented allergy to testosterone
•Age > 80 years
•Pregnancy or breast feeding
•Patient under legal guardianship

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath